Last reviewed · How we verify

NCT05009849

Role of Exercise in Breast Cancer Patient Undergoing Treatment

Active, enrolled NA Last updated 20 October 2022
What this trial tests

NA trial testing Yoga Exercises in Breast Cancer Patients in 850 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
23 November 2010
Primary endpoint
24 May 2025
30 May 2030

Quick facts

Lead sponsorTata Memorial Centre
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment850
Start date23 November 2010
Primary completion24 May 2025
Estimated completion30 May 2030

Drugs / interventions tested

Conditions studied

Sponsor

Tata Memorial Centre — full company profile →

Who can join

Adults 18 to 60, female only, with Breast Cancer Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized controlled trial to evaluate the impact of yoga on QOL is also powered to evaluate the impact of yoga on survival. Study involves various phases of yoga(divided in three phases: Phase I/II/III) during treatment and survivorship, with a comparative analysis of different time points and the response to yoga, which will help integrating yoga as a complementary modality. Also, this study will help identify the long term and short term effects of this therapy in breast cancer patients and survivors. One of the main differences between yoga and other forms of physical activity is that yoga exercises oppose violent muscle movement and is designed to counteract fatigue through relaxation and breathing. 6 monthly Follow Up will be for 5 years followed by yearly follow up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Yoga Exercises

Trials testing the same drug.

Other recruiting trials for Breast Cancer Patients

Currently open trials in the same condition.

Other Tata Memorial Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05009849.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing